Cambridge Investment Research Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,905
| Closed | -$16K | – | 2422 |
|
|
2019
Q1 | $16K | Sell |
5,905
-32
| -0.5% | -$87 | ﹤0.01% | 2260 |
|
|
2018
Q4 | $12K | Buy |
5,937
+32
| +0.5% | +$65 | ﹤0.01% | 2135 |
|
|
2018
Q3 | $27K | Hold |
5,905
| – | – | ﹤0.01% | 2217 |
|
|
2018
Q2 | $27K | Buy |
5,905
+86
| +1% | +$393 | ﹤0.01% | 2183 |
|
|
2018
Q1 | $42K | Buy |
5,819
+270
| +5% | +$1.95K | ﹤0.01% | 2108 |
|
|
2017
Q4 | $40K | Buy |
5,549
+3,911
| +239% | +$28.2K | ﹤0.01% | 2073 |
|
|
2017
Q3 | $14K | Sell |
1,638
-3
| -0.2% | -$26 | ﹤0.01% | 1990 |
|
|
2017
Q2 | $17K | Buy |
1,641
+3
| +0.2% | +$31 | ﹤0.01% | 1916 |
|
|
2017
Q1 | $19K | Buy |
1,638
+250
| +18% | +$2.9K | ﹤0.01% | 1756 |
|
|
2016
Q4 | $18K | Buy |
1,388
+200
| +17% | +$2.59K | ﹤0.01% | 1655 |
|
|
2016
Q3 | $22K | Buy |
1,188
+350
| +42% | +$6.48K | ﹤0.01% | 1724 |
|
|
2016
Q2 | $9K | Buy |
+838
| New | +$9K | ﹤0.01% | 1550 |
|